PharmaTher

Toronto, Canada

PharmaTher Holdings pecializes in the development and commercialization of ketamine-based medicines.

$7.9M raised

Sep 2021

Post-IPO Equity

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about PharmaTher

How much funding has PharmaTher raised?

PharmaTher has raised $7.9M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in September 2021.

Where is PharmaTher headquartered?

PharmaTher is headquartered in Toronto, Canada.

What does PharmaTher do?

PharmaTher Holdings pecializes in the development and commercialization of ketamine-based medicines.

What stage is PharmaTher at?

PharmaTher is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 24, 2021.

MLA

"PharmaTher — Funding & Investors." VCBacked, September 24, 2021, https://www.vcbacked.co/company/pharmather. Accessed July 2, 2026.

APA

VCBacked. (2021). PharmaTher — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/pharmather

Wikipedia (cite web)

{{cite web |title=PharmaTher — Funding & Investors |url=https://www.vcbacked.co/company/pharmather |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 24, 2021.